Recently published TGA #Australia FOI 4251 shows causality assessment outcomes for deaths assessed by the TGA as likely to be linked to COVID-19 vaccination.
In the recent COVID-19 weekly safety report which is now published fortnightly, TGA has advised that to 14 May 2023, TGA has identified 14 reports where the cause of death was linked to vaccination from 985 reports received and reviewed.
After 2 years later, Dept. of Health Australia advised that from 20 March 2023 Vaxzevria (#AstraZeneca) is no longer available as an approved COVID-19 vaccine in #Australia
I think it too late. Millions of people have taken this vaccine in Australia.
ATAGI #Australia advised today:-
A bivalent vaccine (one dose) is preferred over original vaccines (2 doses) for primary vaccination.
Also:-
"While there are currently no efficacy or effectiveness studies of bivalent vaccines when used for the primary vaccination course"
π€‘ππ½π
And perhaps a subtle admission that natural immunity exist π€
"....in the context of widespread community transmission in #Australia which suggests that most previously unvaccinated recipients will have some pre-existing immunity from prior infection."
A π§΅on an interesting development in #Australia regarding COVID-19 vaccine digital certificate which is generated using the Australian Immunisation Register (AIR) which is a national register that records vaccinations given to people of all ages in Australia.
Australians had (still have to in some work sectors) to provide a copy of the COVID-19 digital certificate to their employers to work "on-site" as COVID-19 vaccines and proof of administration was mandated by state governments across #Australia via Public Health Order.
Here is a sample of COVID-19 vaccine digital certificate (now outdated) issued by the Australian Government which will show all the necessary details including the brand of the COVID-19 vaccine, date of vaccination and number of doses.
TGA has finally published (8 May 2023), almost after an year, documentations on death of a 5 year old (M), 7 year old (M) and a 9 year old (F) following #Pfizer COVID-19 vaccine.
TGA #Australia has announced today (3 May 2023), that from 1 June 2023, prescribing of oral #Ivermectin for βoff-labelβ uses will no longer be limited to specialists such as dermatologists, gastroenterologists and infectious diseases specialists.
Excerpt from the document (Notice of final decision) shows how and why it is still considered that #Ivermectin is not a useful prophylaxis/medicine for COVID-19 and instead COVID-19 vaccines and treatments should be preferred.
Note that Pharmacy Guild of #Australia wrote to the panel and advised AGAINST removing the Appendix D entry because they think that if #Ivermectin is available, people may choose not to get vaccinated.
On 20th April 2021, #Pfizer requested waiver for summary of drug utilization rate because data on drug utilization rates in females of reproductive potential was not available for BNT162b2 (mRNA).
Neither Pfizer nor BioNTech compiled data on DUR
among females of reproductive potential because no clinical evidence existed at any point throughout clinical development to indicate that vaccination posed any elevated risk to women of this group.
The Advisory Committee on Immunization Practices (ACIP) stated that based on current knowledge (animal tests), COVID-19 vaccines unlikely posed a risk to the pregnant women or the fetus because authorized COVID-19 vaccines are non-replicating vaccines.
A π§΅on recent #Pfizer documents published early April 2023.
#pfizer searched their safety database for all BNT162b2 vaccine cases reporting any exposure to
vaccine during pregnancy or exposure to baby via lactation from all time through 28 February 2021.
673 cases identified.
Out of 673 identified cases:-
- 458 involved BNT162b2 exposure during
pregnancy (mother/fetus)